EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Acetylcysteine for delayed cognitive deterioration after acute carbon monoxide poisoning: A pilot randomized controlled trial

Han-Wei Mu, Fen-Wei Huang, Chun-Yen Kuo, Hong-Mo Shih, Kai-Wei Yang, Chun-Hung Chen, Dong-Zong Hung

Human & Experimental Toxicology · 2026-07 · 45

DOI: 10.1177/09603271261467145 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Human & Experimental Toxicology, online erschienen am 07.07.2026. Verfasst von Han-Wei Mu und 6 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Medical University Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Delayed neurological complications are an important cause of disability after acute carbon monoxide (CO) poisoning, but an effective pharmacological preventive treatment has not been established. Acetylcysteine may reduce oxidative injury after CO exposure and could therefore lower the risk of later cognitive deterioration.

Methods

In this single-blinded randomized pilot trial, 63 adults with acute CO poisoning were assigned to receive either intravenous acetylcysteine at 300 mg/kg/day for 3 days or placebo, in addition to standard hyperbaric oxygen. The primary outcome was delayed cognitive deterioration, measured as change in Mini-Mental State Examination category between recovery from the acute episode and 3-month follow-up, signaling worsening cognitive status.

Results

In the intention-to-treat population, delayed cognitive deterioration occurred in 2 of 31 patients (6.5%) in the acetylcysteine group, and in 5 of 32 patients (15.6%) in the placebo group. The difference did not reach statistical significance (odds ratio: 0.37, 95% CI: 0.07–2.08, Fisher’s exact p=0.426). No serious adverse effects were observed.

Conclusion

Adjunctive intravenous acetylcysteine did not significantly reduce delayed cognitive deterioration in this pilot study. Any apparent inter-group difference should be interpreted cautiously given the limited sample size and the MMSE-based outcome definition. Further studies with larger samples and more standardized outcome assessment are needed.

Förderung

  • China Medical University Hospital

Zitieren

APA

Mu, H., Huang, F., Kuo, C., Shih, H., Yang, K., Chen, C., & Hung, D. (2026). Acetylcysteine for delayed cognitive deterioration after acute carbon monoxide poisoning: A pilot randomized controlled trial. Human & Experimental Toxicology, 45. https://doi.org/10.1177/09603271261467145

Vancouver

Mu H, Huang F, Kuo C, Shih H, Yang K, Chen C, et al. Acetylcysteine for delayed cognitive deterioration after acute carbon monoxide poisoning: A pilot randomized controlled trial. Human & Experimental Toxicology. 2026;45. doi:10.1177/09603271261467145

BibTeX
@article{Mu2026,
  author = {Mu, Han-Wei and Huang, Fen-Wei and Kuo, Chun-Yen and Shih, Hong-Mo and Yang, Kai-Wei and Chen, Chun-Hung and Hung, Dong-Zong},
  title = {Acetylcysteine for delayed cognitive deterioration after acute carbon monoxide poisoning: A pilot randomized controlled trial},
  journal = {Human & Experimental Toxicology},
  year = {2026},
  volume = {45},
  doi = {10.1177/09603271261467145}
}
Kostenlos starten →